JP2009502405A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502405A5
JP2009502405A5 JP2008524655A JP2008524655A JP2009502405A5 JP 2009502405 A5 JP2009502405 A5 JP 2009502405A5 JP 2008524655 A JP2008524655 A JP 2008524655A JP 2008524655 A JP2008524655 A JP 2008524655A JP 2009502405 A5 JP2009502405 A5 JP 2009502405A5
Authority
JP
Japan
Prior art keywords
drugs
combinations
phase
composite material
polyvinyl alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008524655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009502405A (ja
JP5180075B2 (ja
Filing date
Publication date
Priority claimed from IT000549A external-priority patent/ITTO20050549A1/it
Application filed filed Critical
Publication of JP2009502405A publication Critical patent/JP2009502405A/ja
Publication of JP2009502405A5 publication Critical patent/JP2009502405A5/ja
Application granted granted Critical
Publication of JP5180075B2 publication Critical patent/JP5180075B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008524655A 2005-08-03 2006-08-01 代用骨としての使用に適した注射可能な複合材料 Expired - Fee Related JP5180075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITTO2005A000549 2005-08-03
IT000549A ITTO20050549A1 (it) 2005-08-03 2005-08-03 Materiale composito iniettabile atto ad essere utilizzato come sostituto osseo
PCT/IB2006/052623 WO2007015208A2 (en) 2005-08-03 2006-08-01 Injectable composite material suitable for use as a bone substitute

Publications (3)

Publication Number Publication Date
JP2009502405A JP2009502405A (ja) 2009-01-29
JP2009502405A5 true JP2009502405A5 (enExample) 2012-10-18
JP5180075B2 JP5180075B2 (ja) 2013-04-10

Family

ID=37667630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008524655A Expired - Fee Related JP5180075B2 (ja) 2005-08-03 2006-08-01 代用骨としての使用に適した注射可能な複合材料

Country Status (22)

Country Link
US (2) US20080220086A1 (enExample)
EP (1) EP1924302B1 (enExample)
JP (1) JP5180075B2 (enExample)
KR (1) KR101276632B1 (enExample)
CN (1) CN101257937B (enExample)
AT (1) ATE465762T1 (enExample)
AU (1) AU2006274594B2 (enExample)
BR (1) BRPI0615994A2 (enExample)
CA (1) CA2617721A1 (enExample)
DE (1) DE602006014004D1 (enExample)
DK (1) DK1924302T3 (enExample)
ES (1) ES2345399T3 (enExample)
IT (1) ITTO20050549A1 (enExample)
NZ (1) NZ566086A (enExample)
PL (1) PL1924302T3 (enExample)
PT (1) PT1924302E (enExample)
RU (1) RU2407552C2 (enExample)
SI (1) SI1924302T1 (enExample)
SM (1) SMP200800013B (enExample)
UA (1) UA92027C2 (enExample)
WO (1) WO2007015208A2 (enExample)
ZA (1) ZA200801928B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235592B2 (en) 2004-10-12 2007-06-26 Zimmer Gmbh PVA hydrogel
US20070098799A1 (en) * 2005-10-28 2007-05-03 Zimmer, Inc. Mineralized Hydrogels and Methods of Making and Using Hydrogels
EP2340855A1 (en) 2005-12-07 2011-07-06 Zimmer, Inc. Methods of modifying hydrogels using irradiation
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US7731988B2 (en) 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
US20100226956A1 (en) 2009-03-06 2010-09-09 Per Kjellin Production of moldable bone substitute
ES2981890T3 (es) 2015-07-24 2024-10-11 Trimph Ip Pty Ltd Polímero antiséptico y síntesis del mismo
JP2020067494A (ja) * 2018-10-22 2020-04-30 ウェトラブ株式会社 脳神経外科手術用頭部モデル

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3635316B2 (ja) * 1996-11-25 2005-04-06 株式会社アドバンス 球状セラミックス多孔体の製造方法
PL363113A1 (en) * 2000-03-27 2004-11-15 Schott Glas New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
US6949251B2 (en) 2001-03-02 2005-09-27 Stryker Corporation Porous β-tricalcium phosphate granules for regeneration of bone tissue
US20050049715A1 (en) * 2001-10-21 2005-03-03 Atsuo Ito Porous article of sintered calclium phosphate, process for producing the same and artificial bone and histomorphological scaffold using the same
CA2537735C (en) 2003-09-12 2018-07-24 Wyeth Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins

Similar Documents

Publication Publication Date Title
JP2009524695A5 (enExample)
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
IL189856A (en) Pharmaceutical tablets containing high doses of metformin and also wildglyphatin and processes for their preparation
IL225206A (en) A derivative of multinuclear carbamoylpyridone, its pharmaceutical composition and its use
EP2095939A4 (en) COMPOSITION AND COMPOSITION OF COMPREHENSIVE ABSORBENT ARTICLE
EP2085078A4 (en) OSMOTIC PUMP TABLET WITH CONTROLLED POROSITY OF HIGHLY PERMEABLE MEDICINES AND PREPARATION METHOD THEREOF
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
JP2007169302A5 (enExample)
HUS1800034I1 (hu) Anti-FGF23 ellenanyag és anti-FGF23 ellenanyagot tartalmazó gyógyászati készítmény
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
IL205398A0 (en) New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs
JP2010539123A5 (enExample)
CL2007001630A1 (es) Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
JP2009502405A5 (enExample)
EP2094711B8 (de) Strukturmimetika prolinreicher peptide und ihre pharmazeutische verwendung
JP2007520565A5 (enExample)
JP2006511228A5 (enExample)
EP2090424A4 (en) COMPOSITION AND COMPOSITION OF COMPREHENSIVE ABSORBENT ARTICLE
PT2205526T (pt) Óxidos cerâmicos esféricos e nanocristalinos, processo para a síntese e sua utilização
BRPI0807989A2 (pt) Composto de éster e uso do mesmo.
ZA201009097B (en) C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter
JP2006305390A5 (enExample)
IL201931A0 (en) Methods for preparing factor x, activated factor x, inactivated factor x and inactivated factor xa, and pharmaceutical compositions comprising same
JP2008542528A5 (enExample)